Recruiting Ankylosing Spondylitis Studies in New York
About Ankylosing Spondylitis Clinical Trials in New York
Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.
There are currently 90 ankylosing spondylitis clinical trials recruiting participants in New York, NY. These studies are seeking a combined 39,678 participants. Research is being sponsored by Renalytix AI, Inc., University of California, San Francisco, Sir Mortimer B. Davis - Jewish General Hospital and 49 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Ankylosing Spondylitis Clinical Trials in New York — FAQ
Are there ankylosing spondylitis clinical trials in New York?
Yes, there are 90 ankylosing spondylitis clinical trials currently recruiting in New York, NY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New York?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.
Are clinical trials in New York free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.
What ankylosing spondylitis treatments are being tested?
The 90 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.
Data updated July 18, 2026 from ClinicalTrials.gov